GlycoLax - 62175-190-14 - (Polyethylene Glycol 3350)

Alphabetical Index


Drug Information of GlycoLax

Product NDC: 62175-190
Proprietary Name: GlycoLax
Non Proprietary Name: Polyethylene Glycol 3350
Active Ingredient(s): 17    g/17g & nbsp;   Polyethylene Glycol 3350
Administration Route(s): ORAL
Dosage Form(s): POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of GlycoLax

Product NDC: 62175-190
Labeler Name: Kremers Urban Pharmaceuticals Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: ANDA090600
Marketing Category: ANDA
Start Marketing Date: 20091006

Package Information of GlycoLax

Package NDC: 62175-190-14
Package Description: 238 g in 1 BOTTLE (62175-190-14)

NDC Information of GlycoLax

NDC Code 62175-190-14
Proprietary Name GlycoLax
Package Description 238 g in 1 BOTTLE (62175-190-14)
Product NDC 62175-190
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Polyethylene Glycol 3350
Dosage Form Name POWDER, FOR SOLUTION
Route Name ORAL
Start Marketing Date 20091006
Marketing Category Name ANDA
Labeler Name Kremers Urban Pharmaceuticals Inc.
Substance Name POLYETHYLENE GLYCOL 3350
Strength Number 17
Strength Unit g/17g
Pharmaceutical Classes

Complete Information of GlycoLax


General Information